Term
| Ipratropium Bromide Trade name |
|
Definition
|
|
Term
| Ipratropium Bromide Class |
|
Definition
| Bronchodilator, anticholinergic |
|
|
Term
|
Definition
| antagonizes the ACH receptor on bronchial smooth muscle, producing bronchodilation |
|
|
Term
|
Definition
| Asthma Bronchospasm associated with COPD |
|
|
Term
| Ipratropium Bromide Side Effects |
|
Definition
| Paradoxical acute Bronchospasm, cough, throat irritation, headache, dizziness, dry mouth, palpiations |
|
|
Term
| Ipratropium Bromide Contraindications |
|
Definition
| Closed angle glaucoma, bladder neck obstruction, prostatic hypertrophy, known sensitivty to peanuts or soy beans and atropine or atropine derivatives |
|
|
Term
|
Definition
|
|
Term
| Atrovent Dosage Pediatric |
|
Definition
| 5-14 years .25 mg to .5 mg every 20 min for 3 doses as needed |
|
|
Term
| Special Considerations Atrovent |
|
Definition
Atrovent is not typically used as sole medication in treatment of acute exacerbation of asthma. Commonly used after beta agonist.
Not to come in contact with eyes
Pregnancy class B |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Beta 2 agonist Bronchodilator |
|
|
Term
|
Definition
| Binds and stimulates beta 2 receptors, resulting in relaxation of bronchial smooth muscle |
|
|
Term
|
Definition
| Asthma, Bronchitis with bronchospasm and COPD |
|
|
Term
| Albuterol Adverse Effects |
|
Definition
| Hyperglycemia, hypokalemia, palpitations, sinus tachycardia, anxiety, tremor, nausea/vomiting, throat irritation, dry mouth hypertension, dyspepsia, insomnia, headache, episataxis paradoxical Bronchospasms |
|
|
Term
| Albuterol Contraindications |
|
Definition
| Angiodema sensitivity to albuterol or levalbuterol. Lactating patients cardiovascular disorders cardiac arrhythmias |
|
|
Term
|
Definition
| 2.5 to 5mg every 20 min for mnaximum 3 doses. After initial 3 doses escalate the dose or start a continuous nebulization at 10 to 15 mg/hr |
|
|
Term
| Albuterol Dosage Pediatric |
|
Definition
>12 years continuous nebulizer.5mg/kg/hr
<12 .15mg/kg every 20 min for max 3 doses. Alternatively continuous nebulization at .5mg/kg/hr can be delivered to children younger than 12 years |
|
|
Term
| Albuterol Special Considerations |
|
Definition
|
|
Term
Succinylcholine
Trade name |
|
Definition
|
|
Term
Succinylcholine
Classification |
|
Definition
| Neuromuscular blocker, depolarizing |
|
|
Term
|
Definition
| Competes with the acetylcholine receptor of the motor end plate on the muscle cell, resulting in muscle paralysis |
|
|
Term
Succinylcholine
Indications |
|
Definition
| To induce neuromuscular blockade for facilitation of ET intubation |
|
|
Term
Succinylcholine
Adverse effects |
|
Definition
| Anaphlyactoid reactions, respiratory depression, apnea, bronchospasm, cardiac arrhythmias, malignant hyperthermia, hypertension, hypotension, muscle recirculation, postprocedure muscle pain, hypersalivation, rash |
|
|
Term
Succinylcholine
Contraindications |
|
Definition
| Malignant hyperthermia, burns, trauma. Use with caution in children, cardiac disease, hepatic disease, renal, disease, peptic ulcer disease, cholinesterase-inhibitor toxicity, psuedocholinesterase deficiency, digitalis toxicity, glaucoma, hyperkalemia, hypothermia, rhabdomyloysis, myasthenia gravis |
|
|
Term
Succinylcholine
Dosage adult |
|
Definition
IV: 0.6 mg/kg IV, IO Range 0.3-1.1 mg/kg
IM: 3 to 4 mg/kg max dose 150 mg |
|
|
Term
Succinylcholine
Dosage pediatric |
|
Definition
IV:
adolescents and older children: 1 mg/kg IV, IO
small children and infants: 2 mg/kg IV, IO
IM: 3 to 4 mg/kg max dose: 150 mg |
|
|
Term
Succinylcholine
Special considerations |
|
Definition
IV administration results in neuromuscular blockade in 0.5 to 1 minute. IM administration results in neuromuscular blockade in 2 to 3 minutes.
IV administration in infants and children can potentially result in profound tachycardia and, in some cases, asystole. This can be reduced with pretreatment of atropine.
Have prolonged effects in presence of nerve gas and organophosphate pesticides.
Pregnancy class C |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
Prednisone
Adverse effects |
|
Definition
| Typically seen with long term use and withdrawal |
|
|
Term
Prednisone
Contraindications |
|
Definition
| Cushing's syndrome, fungal infections, measles, varicella, known sensitivity |
|
|
Term
|
Definition
| Dosage must be individualized |
|
|
Term
Prednisone
Dosage pediatric |
|
Definition
| Dosage must be individualized |
|
|
Term
|
Definition
|
|
Term
| Vecuronium Classification |
|
Definition
| Neuromuscular blocker, nondepolarizing |
|
|
Term
|
Definition
| Antagonizes the ACH receptors at the motor end plate producing skeletal muscle paralysis |
|
|
Term
|
Definition
| To induce neuromuscular blockade for facilitation of ET intubation |
|
|
Term
| Vecuronium Adverse Effects |
|
Definition
| muscle paralysis, apnea, dyspnea, respitory depression, sinus tachycardia, urticaria |
|
|
Term
| Vecuronium Contraindications |
|
Definition
| Use with caution in heart disease liver disease |
|
|
Term
|
Definition
|
|
Term
| Vecuronium Dosage Pediatric |
|
Definition
| Dosage must be individualized |
|
|
Term
| Vecuronium Special Considerations |
|
Definition
|
|
Term
|
Definition
|
|
Term
| Rocuronium Classification |
|
Definition
| Neuromuscular blocker, nondepolarizing |
|
|
Term
|
Definition
| Antagonizes ACH at the motor end plate producing skeletal muscle paralysis |
|
|
Term
|
Definition
| To induce Neuromuscular blockade to facilitate ET intubation |
|
|
Term
| Rocuronium Adverse Effects |
|
Definition
| muscle paralysis, apnea, dyspnea, respiratory depression, sinus tachycardia, urticaria |
|
|
Term
| Rocuronium Contraindications |
|
Definition
| Use with caution in heart disease, liver disease |
|
|
Term
|
Definition
|
|
Term
| Rocuronium Dosage Pediatric |
|
Definition
| >3 Months 0.6 mg/kg IV IO |
|
|
Term
| Rocuronium Special Considerations |
|
Definition
Onset is 2-8 min
duration of action 31 min
Pregnancy Class B |
|
|
Term
|
Definition
|
|
Term
|
Definition
| hypnotic anesthesia induction agent |
|
|
Term
|
Definition
| appears to have GABA-like effects |
|
|
Term
|
Definition
| induction for RSI and pharmacologic-assisted intubation, induction of anesthesia |
|
|
Term
| Etomidate adverse effects |
|
Definition
| hypotension, respitory depression, pain at injection site, temporary involuntary muscle movements,frequent n/v, adrenal insufficiency, hyperventilation hypoventilation, apnea, hiccups, laryngospasms, snoring, tachypnea, hypertension, cardiac arrythmias |
|
|
Term
| Etomidate contraindications |
|
Definition
| use in pregnancy only if the potential benefits justify the potential risk of the fetus. do not use during labor and avoid use in nursing mothers. |
|
|
Term
|
Definition
.2-.6 slow mg/kg IV IO over 30-60 seconds
typical dose is 20 mg slow IV.
Consider less in elderly or patients with cardiac conditions |
|
|
Term
| Etomidate Dosage Pediatric |
|
Definition
>10 years same as adult dosage
<10 years safety not established |
|
|
Term
| Etomidate Special Considerations |
|
Definition
Etomidate is used to prepare a patient for orotracheal intubation. personel and equipment must be present to manage airway before administration
Pregnancy class C |
|
|
Term
| Methylprednisone Trade Name |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Reduces Inflamation by multiple mechanisms |
|
|
Term
| Methylprednisone Indications |
|
Definition
|
|
Term
| Methylprednisone Adverse Effects |
|
Definition
| depression, euphoria, headache, restlessness, hypertension, bradycardia, n/v, swelling, diarrhea, weakness, fluid retention, paresthesias |
|
|
Term
| Methylprednisone Contraindications |
|
Definition
| cushings syndrome, fungal infections, measles, varicella. use with caution in active infections, renal disease, penetrating spinal cord injury, hypertension, seizures, CHF |
|
|
Term
| Methylprednisone Dosage Adult |
|
Definition
Asthma COPD:
40-80 mg IV
Anaphylactic Shock:
1-2 mg/kg/dose then .5-1 mg/kg every 6 hours
Blunt Spinal Cord Injury:
30mg/kg/hrX1 IV IO then as infusion run dose of 5.4mg/kg/hr for 23 hours |
|
|
Term
| Methylprednisone Dosage Pediatric |
|
Definition
Asthma and COPD:
1 mg/kg (up to 60mg) IV IO per day in 2 divided doses
Anaphylactic Shock:
Same as adult dosing (1-2 mg/kg/dose then .5-1 mg/kg every 6 hours
Blunt spinal cord injury:
Same as adult (30mg/kg/hrX1 IV IO then infusion of 5.4 mg/kg/hr for 23 hours) |
|
|
